A randomized trial that compares Carfilzomib - Lenalidomide - Dexamethasone (KRd) versus Lenalidomide - Dexamethasone (Rd) in new diagnosed myeloma patients not elegible for trasplant.

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2024
This article has no abstract
Epistemonikos ID: c83d43e80e84d1b3ba8cfe5acad3524fe00d8205
First added on: Mar 21, 2025